NCT07091942 Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT07081633 Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07078305 Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT07064668 Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study Status NOT_YET_RECRUITING Phase PHASE2
NCT07062055 BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases Status RECRUITING Phase PHASE2
NCT07059494 Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant Status RECRUITING Phase PHASE4
NCT07052448 The Efficacy of Sequential RT After Triple Therapy for uHCC Status ENROLLING_BY_INVITATION Phase N/A
NCT07048665 Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07018518 PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma Status RECRUITING Phase PHASE1
NCT06984718 A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06961617 Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma Status RECRUITING Phase PHASE1
NCT06954467 JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06950827 Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT06940102 Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors Status RECRUITING Phase N/A
NCT06928415 Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT) Status NOT_YET_RECRUITING Phase N/A
NCT06921785 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma Status RECRUITING Phase PHASE3
NCT06905262 Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt) Status RECRUITING Phase N/A
NCT06904170 Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma Status RECRUITING Phase PHASE2/PHASE3